GENERAL DYNAMICS CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that GENERAL DYNAMICS CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $52.55B | Jan 30, 2026 |
| FY2025 | Dec 31, 2024 | $47.72B | Jan 30, 2026 |
| FY2025 | Dec 31, 2023 | $42.27B | Jan 30, 2026 |
| FY2024 | Dec 31, 2022 | $39.41B | Feb 7, 2025 |
| FY2023 | Dec 31, 2021 | $38.47B | Feb 8, 2024 |
| FY2022 | Dec 31, 2020 | $37.93B | Feb 7, 2023 |
| FY2021 | Dec 31, 2019 | $39.35B | Feb 9, 2022 |
| FY2020 | Dec 31, 2018 | $36.19B | Feb 9, 2021 |
| FY2019 | Dec 31, 2017 | $30.97B | Feb 10, 2020 |
| FY2018 | Dec 31, 2016 | $30.56B | Feb 13, 2019 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $52.55B | Jan 30, 2026 |
| FY2025 | Dec 31, 2024 | $47.72B | Jan 30, 2026 |
| FY2025 | Dec 31, 2023 | $42.27B | Jan 30, 2026 |
| FY2024 | Dec 31, 2022 | $39.41B | Feb 7, 2025 |
| FY2023 | Dec 31, 2021 | $38.47B | Feb 8, 2024 |
| FY2022 | Dec 31, 2020 | $37.93B | Feb 7, 2023 |
| FY2021 | Dec 31, 2019 | $39.35B | Feb 9, 2022 |
| FY2020 | Dec 31, 2018 | $36.19B | Feb 9, 2021 |
| FY2019 | Dec 31, 2017 | $30.97B | Feb 10, 2020 |
| FY2018 | Dec 31, 2016 | $30.56B | Feb 13, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.21B | Jan 30, 2026 |
| FY2025 | Dec 31, 2024 | $3.78B | Jan 30, 2026 |
| FY2025 | Dec 31, 2023 | $3.32B | Jan 30, 2026 |
| FY2024 | Dec 31, 2022 | $3.39B | Feb 7, 2025 |
| FY2023 | Dec 31, 2021 | $3.26B | Feb 8, 2024 |
| FY2022 | Dec 31, 2020 | $3.17B | Feb 7, 2023 |
| FY2021 | Dec 31, 2019 | $3.48B | Feb 9, 2022 |
| FY2020 | Dec 31, 2018 | $3.35B | Feb 9, 2021 |
| FY2019 | Dec 31, 2017 | $2.91B | Feb 10, 2020 |
| FY2018 | Dec 31, 2016 | $2.57B | Feb 13, 2019 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.36B | Jan 30, 2026 |
| FY2025 | Dec 31, 2024 | $4.80B | Jan 30, 2026 |
| FY2025 | Dec 31, 2023 | $4.25B | Jan 30, 2026 |
| FY2024 | Dec 31, 2022 | $4.21B | Feb 7, 2025 |
| FY2023 | Dec 31, 2021 | $4.16B | Feb 8, 2024 |
| FY2022 | Dec 31, 2020 | $4.13B | Feb 7, 2023 |
| FY2021 | Dec 31, 2019 | $4.57B | Feb 9, 2022 |
| FY2020 | Dec 31, 2018 | $4.39B | Feb 9, 2021 |
| FY2019 | Dec 31, 2017 | $4.24B | Feb 10, 2020 |
| FY2018 | Dec 31, 2016 | $3.74B | Feb 13, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Dec 31, 2012 | $1.61B | Feb 8, 2013 |
| FY2012 | Dec 31, 2011 | $1.54B | Feb 8, 2013 |
| FY2012 | Dec 31, 2010 | $1.20B | Feb 8, 2013 |
| FY2010 | Dec 31, 2009 | $925.00M | Feb 18, 2011 |
| FY2010 | Dec 31, 2008 | $686.00M | Feb 18, 2011 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.12B | Jan 30, 2026 |
| FY2025 | Dec 31, 2024 | $4.11B | Jan 30, 2026 |
| FY2025 | Dec 31, 2023 | $4.71B | Jan 30, 2026 |
| FY2024 | Dec 31, 2022 | $4.58B | Feb 7, 2025 |
| FY2023 | Dec 31, 2021 | $4.27B | Feb 8, 2024 |
| FY2022 | Dec 31, 2020 | $3.86B | Feb 7, 2023 |
| FY2021 | Dec 31, 2019 | $2.98B | Feb 9, 2022 |
| FY2020 | Dec 31, 2018 | $3.15B | Feb 9, 2021 |
| FY2019 | Dec 31, 2017 | $3.88B | Feb 10, 2020 |
| FY2015 | Dec 31, 2015 | $2.50B | Feb 8, 2016 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.16B | Jan 30, 2026 |
| FY2025 | Dec 31, 2024 | $916.00M | Jan 30, 2026 |
| FY2025 | Dec 31, 2023 | $904.00M | Jan 30, 2026 |
| FY2024 | Dec 31, 2022 | $1.11B | Feb 7, 2025 |
| FY2023 | Dec 31, 2021 | $887.00M | Feb 8, 2024 |
| FY2022 | Dec 31, 2020 | $967.00M | Feb 7, 2023 |
| FY2021 | Dec 31, 2019 | $987.00M | Feb 9, 2022 |
| FY2020 | Dec 31, 2018 | $690.00M | Feb 9, 2021 |
| FY2019 | Dec 31, 2017 | $428.00M | Feb 10, 2020 |
| FY2018 | Dec 31, 2016 | $392.00M | Feb 13, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $57.25B | Jan 30, 2026 |
| FY2025 | Dec 31, 2024 | $55.88B | Jan 30, 2026 |
| FY2025 | Dec 31, 2023 | $54.81B | Jan 30, 2026 |
| FY2024 | Dec 31, 2022 | $51.59B | Feb 7, 2025 |
| FY2023 | Dec 31, 2021 | $50.07B | Feb 8, 2024 |
| FY2022 | Dec 31, 2020 | $51.31B | Feb 7, 2023 |
| FY2021 | Dec 31, 2019 | $49.35B | Feb 9, 2022 |
| FY2020 | Dec 31, 2018 | $45.89B | Feb 9, 2021 |
| FY2019 | Dec 31, 2017 | $35.05B | Feb 10, 2020 |
| FY2018 | Dec 31, 2016 | $33.17B | Feb 13, 2019 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $25.62B | Jan 30, 2026 |
| FY2025 | Dec 31, 2024 | $22.06B | Jan 30, 2026 |
| FY2025 | Dec 31, 2023 | $21.30B | Jan 30, 2026 |
| FY2025 | Dec 31, 2022 | $18.57B | Jan 30, 2026 |
| FY2024 | Dec 31, 2021 | $17.64B | Feb 7, 2025 |
| FY2023 | Dec 31, 2020 | $15.66B | Feb 8, 2024 |
| FY2022 | Dec 31, 2019 | $13.98B | Feb 7, 2023 |
| FY2021 | Dec 31, 2018 | $12.11B | Feb 9, 2022 |
| FY2020 | Dec 31, 2017 | $11.80B | Feb 9, 2021 |
| FY2019 | Dec 31, 2016 | $10.30B | Feb 10, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $21.01B | Jan 30, 2026 |
| FY2025 | Dec 31, 2024 | $20.56B | Jan 30, 2026 |
| FY2025 | Dec 31, 2023 | $20.59B | Jan 30, 2026 |
| FY2024 | Dec 31, 2022 | $20.33B | Feb 7, 2025 |
| FY2023 | Dec 31, 2021 | $20.10B | Feb 8, 2024 |
| FY2022 | Dec 31, 2020 | $20.05B | Feb 7, 2023 |
| FY2021 | Dec 31, 2019 | $19.68B | Feb 9, 2022 |
| FY2020 | Dec 31, 2018 | $19.59B | Feb 9, 2021 |
| FY2019 | Apr 1, 2018 | $11.96B | Feb 10, 2020 |
| FY2019 | Dec 31, 2017 | $11.91B | Feb 10, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $44.08B | Jan 30, 2026 |
| FY2025 | Dec 31, 2024 | $41.49B | Jan 30, 2026 |
| FY2024 | Dec 31, 2023 | $39.27B | Feb 7, 2025 |
| FY2023 | Dec 31, 2022 | $37.40B | Feb 8, 2024 |
| FY2022 | Dec 31, 2021 | $35.42B | Feb 7, 2023 |
| FY2021 | Dec 31, 2020 | $33.50B | Feb 9, 2022 |
| FY2020 | Dec 31, 2019 | $31.63B | Feb 9, 2021 |
| FY2019 | Dec 31, 2018 | $29.33B | Feb 10, 2020 |
| FY2018 | Dec 31, 2017 | $26.44B | Feb 13, 2019 |
| FY2017 | Dec 31, 2016 | $24.54B | Feb 12, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.33B | Jan 30, 2026 |
| FY2025 | Dec 31, 2024 | $1.70B | Jan 30, 2026 |
| FY2024 | Dec 31, 2023 | $1.91B | Feb 7, 2025 |
| FY2023 | Dec 31, 2022 | $1.24B | Feb 8, 2024 |
| FY2022 | Dec 31, 2021 | $1.60B | Feb 7, 2023 |
| FY2021 | Dec 31, 2020 | $2.82B | Feb 9, 2022 |
| FY2020 | Dec 31, 2019 | $902.00M | Feb 9, 2021 |
| FY2019 | Dec 31, 2018 | $963.00M | Feb 10, 2020 |
| FY2018 | Dec 31, 2017 | $2.98B | Feb 13, 2019 |
| FY2018 | Dec 31, 2016 | $2.33B | Feb 13, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.07B | Jan 30, 2026 |
| FY2024 | Dec 31, 2024 | $8.83B | Feb 7, 2025 |
| FY2023 | Dec 31, 2023 | $9.34B | Feb 8, 2024 |
| FY2022 | Dec 31, 2022 | $10.59B | Feb 7, 2023 |
| FY2021 | Dec 31, 2021 | $11.61B | Feb 9, 2022 |
| FY2020 | Dec 31, 2020 | $13.12B | Feb 9, 2021 |
| FY2019 | Dec 31, 2019 | $12.01B | Feb 10, 2020 |
| FY2018 | Dec 31, 2018 | $12.52B | Feb 13, 2019 |
| FY2017 | Dec 31, 2017 | $4.03B | Feb 12, 2018 |
| FY2016 | Dec 31, 2016 | $3.92B | Feb 6, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 15 | Jan 30, 2026 |
| FY2025 | Dec 31, 2024 | 13 | Jan 30, 2026 |
| FY2025 | Dec 31, 2023 | 12 | Jan 30, 2026 |
| FY2024 | Dec 31, 2022 | 12 | Feb 7, 2025 |
| FY2023 | Dec 31, 2021 | 11 | Feb 8, 2024 |
| FY2022 | Dec 31, 2020 | 11 | Feb 7, 2023 |
| FY2021 | Dec 31, 2019 | 12 | Feb 9, 2022 |
| FY2020 | Dec 31, 2018 | 11 | Feb 9, 2021 |
| FY2019 | Dec 31, 2017 | 9 | Feb 10, 2020 |
| FY2018 | Dec 31, 2016 | 8 | Feb 13, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 15 | Jan 30, 2026 |
| FY2025 | Dec 31, 2024 | 13 | Jan 30, 2026 |
| FY2025 | Dec 31, 2023 | 12 | Jan 30, 2026 |
| FY2024 | Dec 31, 2022 | 12 | Feb 7, 2025 |
| FY2023 | Dec 31, 2021 | 11 | Feb 8, 2024 |
| FY2022 | Dec 31, 2020 | 11 | Feb 7, 2023 |
| FY2021 | Dec 31, 2019 | 11 | Feb 9, 2022 |
| FY2020 | Dec 31, 2018 | 11 | Feb 9, 2021 |
| FY2019 | Dec 31, 2017 | 9 | Feb 10, 2020 |
| FY2018 | Dec 31, 2016 | 8 | Feb 13, 2019 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 270.39M | Jan 30, 2026 |
| FY2025 | Dec 31, 2024 | 270.34M | Jan 30, 2026 |
| FY2024 | Dec 31, 2023 | 273.60M | Feb 7, 2025 |
| FY2023 | Dec 31, 2022 | 274.41M | Feb 8, 2024 |
| FY2022 | Dec 31, 2021 | 277.62M | Feb 7, 2023 |
| FY2021 | Dec 31, 2020 | 286.48M | Feb 9, 2022 |
| FY2020 | Dec 31, 2019 | 289.61M | Feb 9, 2021 |
| FY2019 | Dec 31, 2018 | 288.70M | Feb 10, 2020 |
| FY2018 | Dec 31, 2017 | 296.90M | Feb 13, 2019 |
| FY2017 | Dec 31, 2016 | 302.42M | Feb 12, 2018 |